Authors:
FETY R
ROLLAND F
BARBERIHEYOB M
HARDOUIN A
CAMPION L
CONROY T
MERLIN JL
RIVIERE A
PERROCHEAU G
ETIENNE MC
MILANO G
Citation: R. Fety et al., CLINICAL IMPACT OF PHARMACOKINETICALLY-GUIDED DOSE ADAPTATION OF 5-FLUOROURACIL - RESULTS FROM A MULTICENTRIC RANDOMIZED TRIAL IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS, Clinical cancer research, 4(9), 1998, pp. 2039-2045
Authors:
ZINUTTI C
BARBERIHEYOB M
HOFFMAN M
MAINCENT P
Citation: C. Zinutti et al., IN-VIVO EVALUATION OF SUSTAINED-RELEASE MICROSPHERES OF 5-FU IN RABBITS, International journal of pharmaceutics, 166(2), 1998, pp. 231-234
Authors:
MIRJOLET JF
BARBERIHEYOB M
MERLIN JL
MARCHAL S
ETIENNE MC
MILANO G
BEY P
Citation: Jf. Mirjolet et al., THYMIDYLATE SYNTHASE EXPRESSION AND ACTIVITY - RELATION TO S-PHASE PARAMETERS AND 5-FLUOROURACIL SENSITIVITY, British Journal of Cancer, 78(1), 1998, pp. 62-68
Authors:
BARBERIHEYOB M
REZZOUG H
MERLIN JL
GUILLEMIN F
Citation: M. Barberiheyob et al., SENSITIVE ISOCRATIC LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF 5,10,15,20-TETRA(M-HYDROXYPHENYL)CHLORIN IN PLASMA AND TISSUE WITH ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical sciences and applications, 688(2), 1997, pp. 331-338
Authors:
BEZDETNAYA L
ZEGHARI N
BELITCHENKO I
BARBERIHEYOB M
MERLIN JL
POTAPENKO A
GUILLEMIN F
Citation: L. Bezdetnaya et al., SPECTROSCOPIC AND BIOLOGICAL TESTING OF PHOTOBLEACHING OF PORPHYRINS IN SOLUTIONS, Photochemistry and photobiology, 64(2), 1996, pp. 382-386
Authors:
BACHMANNMOISSON N
BARBERIHEYOB M
MERLIN JL
LEDRICH ML
BATT AM
GUILLEMIN F
Citation: N. Bachmannmoisson et al., CYTOTOXICITY OF TAMOXIFEN AND ITS MAJOR M ETABOLITES IN BREAST-CANCERCELL-LINES, Bulletin du cancer, 83(10), 1996, pp. 809-815
Authors:
REZZOUG H
BARBERIHEYOB M
MERLIN JL
BOLOTINE L
LIGNON D
GUILLEMIN F
Citation: H. Rezzoug et al., IN-VITRO COMPARISON OF THE PHOTODYNAMIC A CTIVITY OF MESO-TETRA (M-HYDROXYPHENYL) CHLORIN AND HEMATOPORPHYRIN DERIVATIVE, Bulletin du cancer, 83(10), 1996, pp. 816-822
Authors:
BARBERIHEYOB M
MERLIN JL
VIGNERON M
CONROY T
Citation: M. Barberiheyob et al., ADDITION OF HEPARIN IN 5-FLUOROURACIL SOLUTION FOR PORTAL-VEIN INFUSION HAS NO INFLUENCE ON ITS STABILITY UNDER CLINICALLY RELEVANT CONDITIONS, Anti-cancer drugs, 6(1), 1995, pp. 163-164
Authors:
BARBERIHEYOB M
WEBER B
MERLIN JL
DITTRICH C
DEBRUIJN EA
LUPORSI E
GUILLEMIN F
Citation: M. Barberiheyob et al., EVALUATION OF PLASMA 5-FLUOROURACIL NUCLEOSIDE LEVELS IN PATIENTS WITH METASTATIC BREAST-CANCER - RELATIONSHIPS WITH TOXICITIES, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 110-116
Authors:
FETY R
ROLLAND F
BARBERIHEYOB M
MERLIN JL
CONROY T
HARDOUIN A
RIVIERE A
MILANO G
Citation: R. Fety et al., CLINICAL RANDOMIZED STUDY OF 5FU MONITORING VERSUS STANDARD-DOSE IN PATIENTS WITH HEAD AND NECK-CANCER - PRELIMINARY-RESULTS, Anticancer research, 14(6A), 1994, pp. 2347-2352
Authors:
BARBERIHEYOB M
MERLIN JL
PONS L
CALCO M
WEBER B
Citation: M. Barberiheyob et al., A SENSITIVE ISOCRATIC LIQUID-CHROMATOGRAPHY ASSAY FOR THE DETERMINATION OF DIPYRIDAMOLE IN PLASMA WITH ELECTROCHEMICAL DETECTION, Journal of liquid chromatography, 17(8), 1994, pp. 1837-1848
Authors:
BARBERIHEYOB M
GRIFFON G
MERLIN JL
WEBER B
Citation: M. Barberiheyob et al., SEQUENCE-DEPENDENT GROWTH-INHIBITORY EFFECTS OF THE IN-VITRO COMBINATION OF FLUOROURACIL, CISPLATIN, AND DIPYRIDAMOLE, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 163-170